CytomX Therapeutics (CTMX) PT Raised to $12 at Piper Sandler

March 23, 2026 9:29 AM

Piper Sandler analyst Edward Tenthoff raised the price target on CytomX Therapeutics (NASDAQ: CTMX) to $12.00 (from $10.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found